Different from the current combination therapy for T2DM complicated with HF, the regulation of insulin signaling pathway can provide targeted treatment for the special combination, improve the common physiological and pathological characteristics of the two diseases, delay the development of T2DM complicated with HF, and ensure a good prognosis. The gene discussed is INS; the disease is hydrops fetalis.